Devices and methods for delivery of bioactive agents

Patent metadata

Field	Value
Publication number	US-10058634-B2
Application number	US-76912710-A
Country	US
Kind code	B2
Filing date	Apr 28, 2010
Priority date	Apr 28, 2009
Publication date	Aug 28, 2018
Grant date	Aug 28, 2018

Abstract

Embodiments of the invention include bioactive agent eluting devices. In an embodiment the invention includes a bioactive agent delivery device including a substrate, a hydrophilic polymer disposed on the substrate, and a substantially amorphous bioactive agent disposed on the surface of the hydrophilic polymer. In an embodiment, the invention includes a method of making a bioactive agent delivery device including depositing a hydrophilic polymer on a substrate forming a hydrophilic surface and depositing a substantially amorphous bioactive agent on the hydrophilic surface. In an embodiment, the invention includes a bioactive agent-eluting catheter including a catheter shaft and an expandable balloon disposed on the catheter shaft. Other embodiments are included herein.

First claim

The invention claimed is:

1. A bioactive agent delivery device comprising:
an expandable substrate forming part of a balloon;
a hydrophilic polymer covalently bonded to the substrate through the reaction product of a latent photoreactive group; and
a substantially amorphous hydrophobic bioactive agent composition layer disposed over the surface of the hydrophilic polymer,
the substantially amorphous hydrophobic bioactive agent composition layer comprising a substantially amorphous hydrophobic bioactive agent selected from the group consisting of paclitaxel, taxane, rapamycin and rapalogs;
the hydrophilic polymer selected from the group consisting of poly(acrylamide), poly(methacrylamide), poly(vinylpyrrolidone), and vinyl pyrrolidone/(meth)acrylamide copolymers,
wherein the substantially amorphous bioactive agent composition layer is applied over the hydrophilic layer using a solvent that does not solvate the hydrophilic polymer;
wherein the amorphous bioactive agent releases from the surface of the hydrophilic polymer when exposed to an aqueous environment and
wherein the amorphous bioactive agent releases from the device into an aqueous environment in under 30 seconds when exposed to an aqueous environment.

2. The bioactive agent delivery device of claim 1 , the substantially amorphous bioactive agent composition disposed on the surface of the hydrophilic polymer without penetrating into the hydrophilic polymer.

3. The bioactive agent delivery device of claim 1 , the amorphous bioactive agent composition comprising trace amounts of the solvent that does not solvate the hydrophilic polymer.

4. A bioactive agent-eluting catheter comprising:
a catheter shaft;
an expandable balloon disposed on the catheter shaft;
a hydrophilic polymer disposed on the outside surface of the balloon, wherein the hydrophilic polymer covalently bonded to the substrate through the reaction product of a latent photoreactive group, the hydrophilic polymer selected from the group consisting
of poly(acrylamide), poly(methacrylamide), poly(vinylpyrrolidone), and vinyl pyrrolidone/(meth)acrylamide copolymers; and
a substantially amorphous bioactive agent forming a layer disposed over the surface of the hydrophilic polymer,
the substantially amorphous bioactive agent comprising a substantially amorphous hydrophobic bioactive agent selected from the group consisting of paclitaxel, taxane, rapamycin and rapalogs;
wherein the substantially amorphous bioactive agent is applied over the hydrophilic polymer using a solvent that does not solvate the hydrophilic polymer;
wherein the amorphous bioactive agent releases from the surface of the hydrophilic polymer when exposed to an aqueous environment and
wherein the amorphous bioactive agent releases from the device into an aqueous environment in under 30 seconds when exposed to an aqueous environment.

5. The bioactive agent-eluting catheter of claim 4 , the substantially amorphous bioactive agent composition disposed on the surface of the hydrophilic polymer without penetrating into the hydrophilic polymer.

6. The bioactive agent-eluting catheter of claim 4 , the amorphous bioactive agent composition comprising trace amounts of a solvent comprising a compound that does not solvate the hydrophilic polymer.

7. The bioactive agent delivery device of claim 1 , the hydrophilic polymer comprising polyacrylamide and the solvent comprising ethyl acetate.

8. The bioactive agent-eluting catheter of claim 4 , the hydrophilic polymer comprising polyacrylamide and the solvent comprising ethyl acetate.

Assignees

• Chappa Ralph A
• Bach Andrew G
• Surmodics Inc

Inventors

• Chappa Ralph A
• Bach Andrew G

Classifications

• A61L2300/416

  Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus · CPC title

• A61L29/16

  Biologically active materials, e.g. therapeutic substances {(A61L29/048 takes precedence)} · CPC title

• A61P37/06

  Immunosuppressants, e.g. drugs for graft rejection · CPC title

• A61L2300/60

  characterised by a special physical form · CPC title

• A61P35/00

  Antineoplastic agents · CPC title